Cargando...
ABHD6: its place in endocannabinoid signaling and beyond.
The endocannabinoid (eCB) signaling system modulates neurotransmission and inflammation, amongst other physiological functions. Its newest member, α/β-hydrolase domain containing 6 (ABHD6), has emerged as a promising therapeutic target to treat several devastating diseases, including epilepsy. We re...
Guardado en:
| Publicado en: | Trends Pharmacol Sci |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445269/ https://ncbi.nlm.nih.gov/pubmed/30853109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tips.2019.02.002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|